KRISTY SMITH: Open Payments
NPI 1881744886 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 31 payments from 8 companies in 2025. Trend: 2023 $1,091 · 2024 $851 · 2025 $535
Food & beverage: $535
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $196 |
| E.R. Squibb & Sons, L.L.C. | 11 | $150 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: VRAYLAR, COBENFY, INGREZZA, TRINTELLIX, FANAPT, SPRAVATO, AUSTEDO XR, REXULTI.
Industry payments across NV — which companies pay providers there.
